Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD. // Nanomedicine: Nanotechnology, Biology and Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all
Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD. Nanomedicine: Nanotechnology, Biology and Medicine. https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all
“Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD.” Nanomedicine: Nanotechnology, Biology and Medicine.
@article{article59614,
title = {Hepatic delivery of FXR mRNA via lipid nanoparticles enhances the efficacy of a low-dose FXR agonist in the treatment of MASLD},
journal = {Nanomedicine: Nanotechnology, Biology and Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1549963426001371?dgcid=rss_sd_all}
}